ERLOTINIB;
BEVACIZUMAB;
CETUXIMAB;
PROTEIN KINASE INHIBITOR;
BONE CANCER;
CANCER THERAPY;
DRUG COST;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE POLICY;
HUMAN;
KIDNEY CANCER;
LEPTOMENINGEAL METASTASIS;
MEDICAID;
MEDICARE;
METASTASIS;
NON SMALL CELL LUNG CANCER;
OFF LABEL DRUG USE;
ONCOLOGY;
PANCREAS CANCER;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
SHORT SURVEY;
TIME TO TREATMENT;
TREATMENT INDICATION;
UNITED STATES;
COMPARATIVE STUDY;
GOVERNMENT;
LITERATURE;
NEOPLASMS;
PUBLICATION;
STANDARDS;
BEVACIZUMAB;
CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.);
CETUXIMAB;
ERLOTINIB HYDROCHLORIDE;
FORMULARIES AS TOPIC;
HUMANS;
MEDICAL ONCOLOGY;
NEOPLASMS;
OFF-LABEL USE;
PROTEIN KINASE INHIBITORS;
REVIEW LITERATURE AS TOPIC;
UNITED STATES;
Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists
Conti RM, Bernstein AC, Villaflor VM, et al. Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists. J Clin Oncol. 2013;31(9):1134-1139.
Social Security Administration Institutions, etc. 42 USC 1395x, § 1861 Accessed August 5, 2016
Social Security Administration. Compilation of the Social Security Laws. Part E-Miscellaneous Provisions. Definitions of Services, Institutions, etc. 42 USC 1395x, §1861. http://www.ssa.gov/OP-Home/ssact/title18/1861.htm. Accessed August 5, 2016.
Institute of Medicine Washington, DC: National Academies Press
Institute of Medicine. Clinical Practice Guidelines We Can Trust.Washington, DC: National Academies Press; 2011. http://www.nationalacademies.org/hmd/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx.
Prepared by the Duke Evidence Based Practice Center under Contract HHSA 290, 2007 10066 I. Rockville, MD: Agency for Healthcare Research and Quality; April 2009 Accessed August 22, 2016
McKinney R, Abernethy AP, Matchar DB, Wheeler JL. White Paper: Potential Conflict of Interest in the Production of Drug Compendia. Prepared by the Duke Evidence Based Practice Center under Contract HHSA 290 2007 10066 I. Rockville, MD: Agency for Healthcare Research and Quality; April 2009. https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id64TA.pdf. Accessed August 22, 2016.
Financial relationships with industry among National Comprehensive Cancer Network guideline authors
[published online August 25, 2016]
Mitchell AP, Basch EM, Dusetzina SB. Financial relationships with industry among National Comprehensive Cancer Network guideline authors [published online August 25, 2016]. JAMA Oncol. doi:10.1001/jamaoncol.2016.2710
